To ensure artificial pancreas systems remain on track at the U.S. Food and Drug Administration (FDA), Senator Susan Collins of Maine, Co-Chair of the Senate Diabetes Caucus, posed a question to FDA Commissioner Margaret Hamburg at a Senate hearing earlier this month.  Check out Senator Collins asking the question, and see Commissioner Hamburg’s response here – https://www.youtube.com/watch?v=5oTQ07tKtDM&feature=youtu.be